Form 4: Allovir Director Vikas Sinha Reports Sale of Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Vikas Sinha, a director and officer of Allovir, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On April 2, 2024, Vikas Sinha, a director, 10% owner, and officer (President and CFO) of Allovir, Inc. [ALVR], sold 885 shares of common stock at a weighted average price of $0.772.
  • The sale was to cover tax withholding obligations related to the vesting of restricted stock units and was automatic.
  • Following the transaction, Sinha directly owns 1,141,474 shares of Allovir common stock.
  • Sinha may be deemed to have shared voting and investment power over 16,674,766 shares held by ElevateBio LLC, where he is a director and CFO, but he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so it doesn't necessarily indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, and 10% owners) of a publicly traded company buy or sell the company's securities. This filing provides transparency into the transactions of company insiders.

Key Dates

DateDescription
04/02/2024Date of the transaction (sale of shares).
04/04/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.